Amedeo Smart

Free Medical Literature Service




  Free Subscription


3 Arch Virol
1 Biochem Soc Trans
1 J Exp Med
1 Lancet
4 Minerva Pediatr (Torino)
4 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
2 PLoS Comput Biol
32 PLoS One
8 Vaccine
6 Virus Res

    Arch Virol

  1. TARE DS, Keng SS, Walimbe AM, Pawar SD, et al
    Phylogeography and gene pool analysis of highly pathogenic avian influenza H5N1 viruses reported in India from 2006 to 2021.
    Arch Virol. 2024;169:111.
    >> Share

  2. YOUSFI FZE, Haroun AE, Nebhani C, Belayachi J, et al
    Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection.
    Arch Virol. 2024;169:109.
    >> Share

  3. HAIDER SA, Jamal Z, Tahir F, Salman M, et al
    Genomic characterization of human respiratory syncytial virus circulating in Islamabad, Pakistan, during an outbreak in 2022-2023.
    Arch Virol. 2024;169:106.
    >> Share

    Biochem Soc Trans

  4. MARINUS T, Foster TL, Tych KM
    The application of single-molecule optical tweezers to study disease-related structural dynamics in RNA.
    Biochem Soc Trans. 2024;52:899-909.
    >> Share


  5. Seven days in medicine: 17-23 April 2024.
    BMJ. 2024;385:q924.
    >> Share

  6. LOOI MK
    Sixty seconds on . . . bird flu.
    BMJ. 2024;385:q951.
    >> Share

  7. KANG D
    The ever looming shadow of caregiving.
    BMJ. 2024;385:q726.
    >> Share

    John Launer: Doctors as activists.
    BMJ. 2024;385:q939.
    >> Share

    J Exp Med

  9. MACLEAN AJ, Bonifacio JPPL, Oram SL, Mohsen MO, et al
    Regulation of pulmonary plasma cell responses during secondary infection with influenza virus.
    J Exp Med. 2024;221:e20232014.
    >> Share


  10. HARRIS E
    Antidepressant Prescriptions for Female Teens Surged After Pandemic.
    JAMA. 2024;331:1266.
    >> Share

  11. HARRIS E
    Deaths From Excessive Drinking Rose in the US During Pandemic.
    JAMA. 2024;331:1355.
    >> Share

  12. HARRIS E
    Meta-Analysis: "Limited" Benefits to Rapid Viral Tests in EDs.
    JAMA. 2024;331:1355.
    >> Share


  13. DEVI S
    Swedish NGOs are reeling after government cuts.
    Lancet. 2024;403:1527.
    >> Share

    Minerva Pediatr (Torino)

  14. MEMEO A, Priano D, Caldarini C, Trezza P, et al
    How the pandemic spread of COVID-19 affected children's traumatology in Italy: changes of numbers, anatomical locations, and severity.
    Minerva Pediatr (Torino). 2024;76:167-172.
    >> Share

  15. GARG D, Bhalla K, Nanda S, Gupta A, et al
    Vitamin D status in children with community acquired pneumonia and its association with severity: a hospital-based study.
    Minerva Pediatr (Torino). 2024;76:227-235.
    >> Share

  16. LEE S, Erdem G, Yasuhara J
    Multisystem inflammatory syndrome in children associated with COVID-19: from pathophysiology to clinical management and outcomes.
    Minerva Pediatr (Torino). 2024;76:268-280.
    >> Share

  17. PEROS TE, Besseling MR, VAN Zanten E, VAN Heerde M, et al
    Increase in pediatric intensive care mortality after the Coronavirus pandemic.
    Minerva Pediatr (Torino). 2023 Sep 21. doi: 10.23736/S2724-5276.23.07288.
    >> Share

    MMWR Morb Mortal Wkly Rep

  18. FRANKLIN D, Barbre K, Rowe TA, Reses HE, et al
    COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:339-344.
    >> Share

  19. ZAMBRANO LD, Newhams MM, Simeone RM, Payne AB, et al
    Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:330-338.
    >> Share

  20. PANAGIOTAKOPOULOS L, Godfrey M, Moulia DL, Link-Gelles R, et al
    Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged >/=65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:377-381.
    >> Share

  21. SMITH-JEFFCOAT SE, Mellis AM, Grijalva CG, Talbot HK, et al
    SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:365-371.
    >> Share

    N Engl J Med

  22. WANG Y, Hu H, Cao B
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply.
    N Engl J Med. 2024;390:1534-1535.
    >> Share

  23. SELVI-SABATER P, de la Rubia Orti JE, Urbieta-Sanz E
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1534.
    >> Share

  24. MOSER CB, Li JZ, Hughes MD
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1533-1534.
    >> Share

    PLoS Comput Biol

  25. BENISTON E, Skittrall JP
    Locations and structures of influenza A virus packaging-associated signals and other functional elements via an in silico pipeline for predicting constrained features in RNA viruses.
    PLoS Comput Biol. 2024;20:e1012009.
    >> Share

  26. LISON A, Abbott S, Huisman J, Stadler T, et al
    Generative Bayesian modeling to nowcast the effective reproduction number from line list data with missing symptom onset dates.
    PLoS Comput Biol. 2024;20:e1012021.
    >> Share

    PLoS One

  27. YAZDANI A, Mozaffarpur SA, Ebrahimi P, Shirafkan H, et al
    Comorbidities affecting re-admission and survival in COVID-19: Application of joint frailty model.
    PLoS One. 2024;19:e0301209.
    >> Share

  28. TIAN J
    Rural household vulnerability and COVID-19: Evidence from India.
    PLoS One. 2024;19:e0301662.
    >> Share

  29. CHAZE M, Meriade L, Rochette C, Bailly M, et al
    Relying on the French territorial offer of thermal spa therapies to build a care pathway for long COVID-19 patients.
    PLoS One. 2024;19:e0302392.
    >> Share

  30. MESESAN-SCHMITZ L, Coman C, Stanciu C, Bucur V, et al
    Changes in parenting behavior in the time of COVID-19: A mixed method approach.
    PLoS One. 2024;19:e0302125.
    >> Share

  31. HAMASHA MM, Alomari AJ, Bani-Irshid AH
    The effect of the COVID-19 pandemic crisis on the Jordanian higher education system.
    PLoS One. 2024;19:e0299531.
    >> Share

  32. RAZAI MS, Mansour R, Ravindran P, Freeman S, et al
    Facilitators and barriers to vaccination uptake in pregnancy: A qualitative systematic review.
    PLoS One. 2024;19:e0298407.
    >> Share

  33. FANG F, Clemens JD, Zhang ZF, Brewer TF, et al
    Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
    PLoS One. 2024;19:e0301830.
    >> Share

  34. CHOUAIRI F, Jaffe E, Minhas AMK, Fudim M, et al
    Brief report: Effect of cardiac multi-morbidity on COVID hospitalization outcomes.
    PLoS One. 2024;19:e0301898.
    >> Share

  35. SHAFIABADY N, Hadjinicolaou N, Hettikankanamage N, MohammadiSavadkoohi E, et al
    eXplainable Artificial Intelligence (XAI) for improving organisational regility.
    PLoS One. 2024;19:e0301429.
    >> Share

  36. BEST LG, Erdei E, Haack K, Kent JW Jr, et al
    Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study.
    PLoS One. 2024;19:e0302464.
    >> Share

  37. WHITE A, Iverson G, Wright L, Fallon JT 3rd, et al
    Wastewater based epidemiology as a surveillance tool during the current COVID-19 pandemic on a college campus (East Carolina University) and its accuracy in predicting SARS-CoV-2 outbreaks in dormitories.
    PLoS One. 2024;19:e0289906.
    >> Share

  38. ZHANG Q, Tiwari S, Wen J, Wang S, et al
    Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice.
    PLoS One. 2024;19:e0300524.
    >> Share

  39. MILANTI A, Chan DNS, Choi KC, So WKW, et al
    eHealth literacy of migrant domestic workers in Hong Kong in the COVID-19 pandemic: A mixed methods study.
    PLoS One. 2024;19:e0296893.
    >> Share

  40. SILVA JUNIOR DDN, de Sousa Mata AN, Silva de Medeiros GCB, Marques MV, et al
    Factors associated with mortality of elderly people due to COVID-19: Protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0289576.
    >> Share

  41. KHAMI MR, Karimi M, Folayan MO, Shamshiri AR, et al
    Patients' knowledge about dental emergencies, COVID-19 transmission, and required preparations in dental settings.
    PLoS One. 2024;19:e0301460.
    >> Share

  42. VIANNA LS, Goncalves AL, Souza JA
    Analysis of learning curves in predictive modeling using exponential curve fitting with an asymptotic approach.
    PLoS One. 2024;19:e0299811.
    >> Share

  43. ZHU Y, Kiran S, Salman M, Sherwani S, et al
    From crisis to responsibility: The role of industry type, leadership style, and regulatory environment in shaping post-COVID-19 CSR initiative.
    PLoS One. 2024;19:e0292732.
    >> Share

  44. ERVIN J, Fleitas Alfonzo L, Taouk Y, Maheen H, et al
    Unpaid caregiving and mental health during the COVID-19 pandemic-A systematic review of the quantitative literature.
    PLoS One. 2024;19:e0297097.
    >> Share

  45. PARK SY, Lee R, Newton C, Han G, et al
    How are people coping with working from home during the COVID-19 pandemic?: Experiences from the Netherlands and South Korea.
    PLoS One. 2024;19:e0301351.
    >> Share

  46. KASSA ZY, Scarf V, Turkmani S, Fox D, et al
    Impact of COVID-19 on antenatal care provision at public hospitals in the Sidama region, Ethiopia: A mixed methods study.
    PLoS One. 2024;19:e0301994.
    >> Share

  47. RAZAFINDRAKOTO M, Roubaud F, Castilho MR, Pero V, et al
    Investigating the 'Bolsonaro effect' on the spread of the Covid-19 pandemic: An empirical analysis of observational data in Brazil.
    PLoS One. 2024;19:e0288894.
    >> Share

  48. MARTINEZ-RAMOS MM, Vyas M, Majari P, Seligman TH, et al
    COVID anomaly in the correlation analysis of S&P 500 market states.
    PLoS One. 2024;19:e0301238.
    >> Share

  49. BADE V, Schmitz H, Tawiah BB
    Regional variations in vaccination against COVID-19 in Germany.
    PLoS One. 2024;19:e0296976.
    >> Share

  50. HONG SH, Jiang X, Kwon H
    Use of bio-information and communication technology shortens time to peak at a lower height of the epidemic curve: An alternative to flattening for countries with early COVID-19 outbreaks.
    PLoS One. 2024;19:e0301669.
    >> Share

  51. HUSSAIN A, Hussain Z, Gogate M, Dashtipour K, et al
    Impact of the Covid-19 pandemic on audiology service delivery: Observational study of the role of social media in patient communication.
    PLoS One. 2024;19:e0288223.
    >> Share

  52. MAJRASHI TA, El Hassab MA, Mahmoud SH, Mostafa A, et al
    In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2.
    PLoS One. 2024;19:e0301086.
    >> Share

  53. COGILL S, Nallamshetty S, Fullenkamp N, Heberer K, et al
    Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning.
    PLoS One. 2024;19:e0290221.
    >> Share

  54. WANG J, Hu L, Zhang T, Liu J, et al
    Prevalence and predictors of prenatal depression during the COVID-19 pandemic: A multistage observational study in Beijing, China.
    PLoS One. 2024;19:e0298314.
    >> Share

  55. DLAMINI M, Msolo L, Ehi Ebomah K, Nontongana N, et al
    A systematic review on the incidence of influenza viruses in wastewater matrices: Implications for public health.
    PLoS One. 2024;19:e0291900.
    >> Share

  56. MAGANA-AVILA GR, Moreno E, Plata C, Carbajal-Contreras H, et al
    Effect of SARS-CoV-2 S protein on the proteolytic cleavage of the epithelial Na+ channel ENaC.
    PLoS One. 2024;19:e0302436.
    >> Share

  57. LEDON-LLANES L, Contreras-Yanez I, Guaracha-Basanez GA, Valverde-Hernandez SS, et al
    Sexual and reproductive health while living with rheumatoid arthritis: The impact of the disease stage on patient perspectives.
    PLoS One. 2024;19:e0302284.
    >> Share

  58. SARVANDIAN S, Hosseinpour S, Hoseinynejad K, Davasaz Irani R, et al
    Mental health status in healthcare workers during COVID-19 pandemic: An online questionnaire study in the southwest Iran.
    PLoS One. 2024;19:e0298058.
    >> Share


  59. SELLIES AJ, Knol MJ, de Melker HE, Bruijning-Verhagen PCJL, et al
    Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections.
    Vaccine. 2024 Apr 23:S0264-410X(24)00468-7. doi: 10.1016/j.vaccine.2024.
    >> Share

  60. NOLAN MB, Chrenka E, Walker P, Steiner A, et al
    COVID-19 vaccine uptake among non-US-born populations in the United States, 2020-2022.
    Vaccine. 2024 Apr 11:S0264-410X(24)00443-2. doi: 10.1016/j.vaccine.2024.
    >> Share

  61. KAINTH MK, Sembajwe GN, Ahn H, Qian M, et al
    Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children.
    Vaccine. 2024 Apr 11:S0264-410X(24)00442-0. doi: 10.1016/j.vaccine.2024.
    >> Share

  62. ARCHER H, McCoy SI, Sears D, Kwan A, et al
    Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021.
    Vaccine. 2024 Apr 6:S0264-410X(24)00368-2. doi: 10.1016/j.vaccine.2024.
    >> Share

  63. SCHULTZE A, Martin I, Messina D, Bots S, et al
    A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases.
    Vaccine. 2024 Apr 5:S0264-410X(24)00330-X. doi: 10.1016/j.vaccine.2024.
    >> Share

  64. NURDIN A, Movieta Nency Y, Maddeppungeng M, Sekartini R, et al
    Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial.
    Vaccine. 2024 Apr 3:S0264-410X(24)00399-2. doi: 10.1016/j.vaccine.2024.
    >> Share

  65. GONG JD, Barnboym E, O'Mara M, Gurevich N, et al
    Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease.
    Vaccine. 2024 Mar 30:S0264-410X(24)00373-6. doi: 10.1016/j.vaccine.2024.
    >> Share

  66. MALTEZOU HC, Kontogianni S, Michailidou E, Vergadi E, et al
    Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19.
    Vaccine. 2024 Mar 30:S0264-410X(24)00397-9. doi: 10.1016/j.vaccine.2024.
    >> Share

    Virus Res

  67. WANG Z, Sun W, Li D, Sun Y, et al
    A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.
    Virus Res. 2024;345:199378.
    >> Share

  68. KHAIRNAR K, Tomar SS
    COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years.
    Virus Res. 2024;344:199365.
    >> Share

  69. LUO L, Lv J
    An evolutionary theory on virus mutation in COVID-19.
    Virus Res. 2024;344:199358.
    >> Share

  70. SCHAFER A, Gralinski LE, Leist SR, Hampton BK, et al
    Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans.
    Virus Res. 2024;344:199357.
    >> Share

  71. SCHMITZ T, Freuer D, Gosslau Y, Warm TD, et al
    Can inflammatory plasma proteins predict Long COVID or Fatigue severity after SARS-CoV-2 infection?
    Virus Res. 2024;344:199363.
    >> Share

  72. KHEMIRI H, Mangone I, Gdoura M, Mefteh K, et al
    Dynamic of SARS-CoV-2 variants circulation in Tunisian pediatric population, during successive waves, from March 2020 to September 2022.
    Virus Res. 2024;344:199353.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016